Autoantibodies to c-myc Protein: Elevated Levels in Patients with African Burkitt's Lymphoma and Normal Ghanians

References

• Tan EM. Autoantibodies to nuclear antigens ANA: Their immunobiology and medicine. Adv in Immunol 1982; 33: 167–240
   PubMed Web of Science ®Google Scholar
• Steinberg AD. Systemic lupus erythematosus: Insights from animal models. Ann Int Med 1984; 100: 714–717
   PubMed Web of Science ®Google Scholar
• Smeland E B, Beiske K, Ed B, Watt R, Pfeiter-Ohlsson S, Blomhoff H K, Godal T, Ohlsson R. Regulation of c-myc transcription and protein expression during activation of normal human B cells. Exp Cell Res 1987; 172: 101–109
   PubMedGoogle Scholar
• Buckler A, Rothstein T L, Sonenshein GE. Two-step stimulation of B lymphocytes to enter DNA synthesis: Synergy between anti-immunoglobulin antibody and cytochalasin in expression of c-myc and a Gl specific gene. Mol Cell Biol 1988; 8: 1371–1375
   PubMedGoogle Scholar
• Kelly K, Cochran B H, Stiles C D, Leder P. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 1983; 35: 603–610
   PubMed Web of Science ®Google Scholar
• Boumpas D T, Tsokos G C, Mann D L, Eleftheriades E G, Harris C C, Mark GE. Increased proto-oncogene expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis and Rheumatism 1986; 29: 755–760
   PubMed Web of Science ®Google Scholar
• Klinman D M, Mushinski J F, Honda M, Ishigatsubo Y, Mountz J D, Raveche E S, Steinberg AD. Oncogene expression in autoimmune and normal peripheral blood mononuclear cells. J. Exp. Med. 1986; 163: 1292–1307
   PubMed Web of Science ®Google Scholar
• Kelly K, Siebenlist U. The regulation and expression of c-myc in normal and malignant cells. Ann Rev Immunol 1986; 4: 317–338
   PubMed Web of Science ®Google Scholar
• Cole MD. The myc oncogene: Its role in transformation and differentiation. Ann Rev Genet 1986; 20: 361–384
   PubMed Web of Science ®Google Scholar
• Spector D L, Watt R A, Sullivan NJ. The v-and c-myc oncogene proteins colocalize in situ with small nuclear ribonucleo-proteins particles. Oncogene 1987; 1: 15–22
   Google Scholar
• Moore J P, Evan GI. Immunoassays for oncoproteins. Nature 1987; 327: 733–734
   Google Scholar
• Dani C H, Blanchard J M, Piechaczyk M, El Sabouty S, Marty L, Jeanteur Ph. Extreme instability of myc mRNA in normal and transformed human cells. Proc Natl Acad Sci USA 1984; 81: 7046–7050
   PubMed Web of Science ®Google Scholar
• Ramsay G, Evan G I, Bishop JM. The protein encoded by the human protooncogene c-myc. Proc Natl Acad Sci USA 1984; 81: 7742–7746
   PubMed Web of Science ®Google Scholar
• Campisi J, Gray H H, Pardee A B, Dean M, Sonenshein GE. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell 1984; 36: 241–247
   PubMed Web of Science ®Google Scholar
• Studzinski G P, Brelvi Z S, Feldman S C, Watt RA. Participation of c-myc protein in DNA synthesis of human cells. Science 1986; 234: 467–470
   PubMed Web of Science ®Google Scholar
• Kaczmarek L, Hyland J, Watt R, Rosenberg M, Baserga R. Microinjected c-myc as a competence factor. Science 1985; 228: 1313–1315
   PubMed Web of Science ®Google Scholar
• Prochownik E V, Kukowska J. Deregulated expression of c-myc by murine erythroleukemia cells prevents differentiation. Nature 1986; 322: 848–850
   PubMed Web of Science ®Google Scholar
• Dmitrovsky E, Kuehl W M, Hollis G F, Kirsch IR, Bender T P, Segal S. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukemia cell line. Nature 1986; 320: 748–750
   Google Scholar
• Coppola J A, Cole MD. Constitutive c-myc oncogene expression blocks mouse erythroleukemia cell differentiation but not commitment. Nature 1986; 320: 760–763
   PubMed Web of Science ®Google Scholar
• Yokota J, Tsunetsugu-Yokota Y, Battifora H, LeFevre C, Cline MJ. Alterations of myc, myb, and rasHA protooncogenes in cancers are frequent and show clinical correlation. Science 1986; 231: 261–265
   PubMed Web of Science ®Google Scholar
• Slamon D J, DeKernion J B, Verna I M, Cline MJ. Expression of cellular oncogcnes in human malignancies. Science 1984; 224: 256–262
   PubMed Web of Science ®Google Scholar
• Shibuya M, Yokota J, Ueyama Y. Amplification and expression of a cellular oncogene (c-myc) in human gastric adcnocarcinoma cells. Mol Cell Biol 1985; 5: 414–418
   PubMedGoogle Scholar
• Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo R C, Croce CM. Human c-wyc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 1982; 79: 7824–7827
   PubMed Web of Science ®Google Scholar
• Guerin M, Lacombe M-J, Riou G. Enhanced expression of the oncogene c-myc in human mammary adenocarcinomas. C R Acad Sci Paris 1985; 301: 833–838
   Google Scholar
• Erisman M D, Scott J K, Watt R A, Astrin S. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines. Oncogene 1988; 2: 367–379
   PubMedGoogle Scholar
• Johnson B D, Ihde D C, Makuch R W, Gazdar A F, Carney D N, Oie H, Russell E, Nau M, Minna JD. Myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. J Clin Invest 1987; 79: 1629–1634
   PubMed Web of Science ®Google Scholar
• Collins S, Groudine M. Amplification of endogenous myc related DNA sequences in a human myeloid leukemia cell line. Nature 1982; 298: 679–681
   PubMed Web of Science ®Google Scholar
• Stewart T A, Pattengale P K, Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 1984; 38: 627–636
   PubMed Web of Science ®Google Scholar
• Adams J M, Harris A W, Pinkert C A, Corcoran L M, Alexander W S, Cory S, Palmiter R D, Brinster RL. The c-myc oncogene driven by immunoglobulin enhancer induces lymphoid malignancy in transgenic mice. Nature 1985; 318: 533–538
   PubMed Web of Science ®Google Scholar
• Leder A, Pattengale P K, Kuo A, Stewart T A, Leder P. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 1986; 45: 485–495
   PubMed Web of Science ®Google Scholar
• Pfeifer-Ohlsson S, Rydnert J, Goustin A S, Larsson E, Betsholtz C, Ohlsson R. Cell-type-specific pattern of myc protooncogene expression in developing human embryos. Proc Natl Acad Sci USA 1985; 82: 5050–5054
   PubMed Web of Science ®Google Scholar
• Pfeifer-Ohlsson S, Goustin A S, Rydnert J, Wahlstrom T, Bjersing L, Stehelin D, Ohlsson R. Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta: implications for embryonic cell proliferation. Cell 1984; 38: 585–596
   PubMed Web of Science ®Google Scholar
• Niman HL. Human oncogene-related proteins in urine during pregnancy and neoplasia. Clinics in Laboratory Medicine 1986; 6: 181–196
   Google Scholar
• Watt R, Shatzman A R, Rosenberg M. Expression and characterization of the human c-mvc DNA-binding protein. Mol Cell Biol 1985; 5: 448–456
   PubMed Web of Science ®Google Scholar
• Tan E M, Kunkel HG. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 1966; 96: 464–471
   PubMed Web of Science ®Google Scholar
• Lerner M R, Steitz JA. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Nail Acad Sci USA 1979; 76: 5495–5499
   PubMed Web of Science ®Google Scholar
• Lerner M R, Boyle J A, Hardin J A, Steitz JA. Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science 1981; 211: 400–402
   PubMed Web of Science ®Google Scholar
• Husby G, Williams R C, Jr. Watt RA, West SG, Tung KSK. Tissue c-myc protein expression and immune response in systemic lupus erythematosus. Clin Exp Immunol 1987; 69: 493–500
   Google Scholar
• Hardin J A, Craft JE. Patterns of autoimmunity to nucleoproteins in patients with systemic lupus erythematosus. Rheumatic Disease Clinics of North America 1987; 13: 37–46
   Google Scholar
• Hardin JA. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis and Rheumatism 1986; 29: 457–460
   PubMed Web of Science ®Google Scholar
• Little C D, Nau MM. Carney DN, Gazdar AF, Minna JD. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 1983; 306: 194–196
   PubMed Web of Science ®Google Scholar
• Wong A J, Ruppert J M, Eggleston J, Hamilton S R, Baylin S B, Vogelstein B. Gene amplification of c-mvc and N-myc in small cell carcinoma of the lung. Science 1986; 233: 461–464
   PubMed Web of Science ®Google Scholar
• Mizuma H, Litwin S, Zolla-Pazner S. B-cell activation in HIV infection: relationship of spontaneous immunological secretion to various immunological parameters. Clin Exp Immunol 1988; 71: 410–416
   PubMed Web of Science ®Google Scholar
• Groopman J E, Sullivan J L, Mulder C, Ginsburg D, Orkin S, O'Hara C, Falchuk K, Wong-Stall F, Gallo RC. Pathogenesis of B cell lymphoma in a patient with AIDS. Blood 1986; 67: 612–615
   PubMed Web of Science ®Google Scholar
• Lane H C, Masur H, Edgar L C, Whalen G, Rook A H, Fauci AA. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Eng J Med 1983; 309: 453–458
   PubMed Web of Science ®Google Scholar
• Pahwa S G, Quilop M TJ, Lange, Pahwa R N, Grieco MH. Defective B-lymphocyte function in homosexual men in relation to the acquired immuno-deficiency syndrome. Ann Inl Med 1984; 101: 757–673
   PubMed Web of Science ®Google Scholar
• Gottlieb M S, Schroff R, Schanker H M. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. N Engl J Med 1981; 305: 1425–1431
   PubMed Web of Science ®Google Scholar
• Friedman-Kien A E, Laubenstein L J, Rubinstein P. Disseminated Kaposi's sarcoma in homosexual men. Ann Int Med 1982; 96: 693–700
   PubMed Web of Science ®Google Scholar
• Seligmann M, Pinching A J, Rosen F S. Immunology of human immunodeficiency virus infection and the acquired immunodeficiency sydnrome. Ann Inl Med 1987; 107: 234–242
   PubMed Web of Science ®Google Scholar
• Ziegler J L, Miner RC, Rosenbaum E. Outbreak of Burkitt's-like lymphoma in homosexual men. The Lancet September, 1982; 18: 631–633
   Google Scholar
• Magrath I, Erikson J, Whang-Peng J, Sieverts H, Armstrong G, Benjamin D, Triche T, Alabaster O, Croce CM. Synthesis of kappa light chains by cell lines containing an 8:22 chromosomal translocation derived from a male homosexual with Burkitt's lymphoma. Science 1983; 222: 1094–1098
   PubMed Web of Science ®Google Scholar
• Pelicci P-G., Knowles DM, Arline ZA. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphopro-liferative disorders. J Exp Med 1986a; 164: 2049–2076
   PubMed Web of Science ®Google Scholar
• Zolla-Pazner S. Laboratory studies in AIDS: serologic studies. Basics of AIDS: A Guide to Clinicians, M. Melbye. Munksgaard, Copenhagen, 151–172
   Google Scholar
• Kopelman R G, Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 1988; 84: 82–88
   PubMed Web of Science ®Google Scholar
• Jacoby D R, Olding L B, Oldstone M BA. Immunologic regulation of fetal-maternal balance. Adv Immunol 1984; 35: 157–208
   PubMedGoogle Scholar
• Croce CM. Role of chromosome translocations in human neoplasia. Cell 1987; 49: 155–156
   PubMed Web of Science ®Google Scholar
• Pelicci P-G, Knowles D M, Magrath I, Dalla-Favera R. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 1986b; 83: 2984–2988
   PubMed Web of Science ®Google Scholar
• Vanio E, Lcnoir G M, Franklin RM. Autoantibodies in three populations of Burkitt's lymphoma patients. Clin Exp Immunol 1983; 54: 387–396
   Google Scholar
• Mori H, Lenoir G M, Franklin RM. Autoantibodies in Burkitt's lymphoma patients from the Ugandan prospective study. Trop Med Parasi 1986; 37: 9–14
   Google Scholar
• Adu D, Williams D G, Quakyi I A, Voller A, Addo-Anim Y, Bruce-Tagoe A A, Johnson G D, Holborow EJ. Anti-ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol 1982; 49: 310–316
   PubMedGoogle Scholar
• Lombardi L, Newcomb E W, Dalla-Favera R. Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 1987; 49: 161–170
   PubMed Web of Science ®Google Scholar
• McCormick N K, McCormick K J, Trentin JJ. Antinuclear antibodies and elevated anti-Epstein-Barr virus tilers in cancer patients. Infection and Immunity 1976; 13: 1382–1386
   Google Scholar
• Blackwood E M, Eisenman RN. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with myc. Science 1991; 251: 1211–1217
   PubMed Web of Science ®Google Scholar
• Evan G I, Lewis G K, Ramsay G, Bishop JM. Isolation of monoclonal antibodies specific for human c-myc protooncogene product. Mol Cell Biol 1985; 5: 3610–361
   PubMed Web of Science ®Google Scholar
• Biggar R J, Henle W, Fleisher G, Bocker J, Lennette E T, Henle G. Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer 1979; 22: 239–243
   Google Scholar
• Biggar R J, Henle G, Bocker J, Lennette E T, Fleisher G, Henle W. Primary Epstein-Barr infections in African Infants. II. Clinical and serological observations during seroconversion. Int. J Cancer 1978; 22: 244–250
   PubMed Web of Science ®Google Scholar